Mar 20, 2026
Mar 20, 2026
Mar 20, 2026
Mar 20, 2026
Mar 20, 2026
Mar 20, 2026
Mar 20, 2026
Mar 20, 2026
Novo Nordisk's stock took a nosedive after a trial failure against Eli Lilly and looming price cuts for Wegovy. Is this a chance to buy the dip or a warning sign?